text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 211555-04-3 | Product Number: W0013

WHI-P154


Purity: >98.0%(HPLC)
Synonyms:
  • 2-Bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol
Product Documents:
10MG
¥205.00
1   Contact Us ≥40 
50MG
¥790.00
Contact Us Contact Us ≥40 

* For order or inquiry, please contact Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.


Product Number W0013
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__6H__1__4BrN__3O__3 = 376.21 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (<0°C)
Condition to Avoid Heat Sensitive
CAS RN 211555-04-3
Reaxys Registry Number 8787580
PubChem Substance ID 468593122
MDL Number

MFCD02179366

Specifications
Appearance White to Yellow to Orange powder to crystal
Purity(HPLC) min. 98.0 area%
Melting point 228.0 to 232.0 °C
Elemental analysis(Nitrogen) 10.50 to 11.50 %
NMR confirm to structure
Properties (reference)
Melting Point 230 °C
Maximum Absorption Wavelength 335(MeOH) nm
GHS
Hazard Statements H413 : May cause long lasting harmful effects to aquatic life.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P273 : Avoid release to the environment.
Related Laws:
Transport Information:
Customs Control Conditions (Q)
Application
WHI-P 154: A Potent Janus-Associated Kinase 3 (JAK3) Inhibitor

WHI-P 154 is a potent Janus-associated kinase 3 (JAK3) inhibitor that displays no activity at JAK1 or JAK2. JAK3 is a cytoplasmic protein tyrosine kinase that functions in the initiation of cytokine-triggered signal transduction by catalyzing the phosphorylation of signal transduction and activators of transcription (STAT). The phosphorylated SATAs are translocated to the nucleus to activate target genes. WHI-P 154 is cytotoxic human glioblastoma cells. Recent reports have indicated that JAK3 is expressed in lymphoid cells and is involved in the signaling of T cell functions. Therefore, the development of a selective JAK3 inhibitor has been shown to have a potential benefit in the treatment of autoimmune disorders. (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Life Science
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.